Liabilities / Assets
55th percentile
Higher debt load relative to assets than 55% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
57th percentile
Higher debt load relative to revenue than 57% of similar nonprofits.
Net Margin
12th percentile
Higher net margin than 12% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
31st percentile
Faster asset growth than 31% of similar nonprofits.
Revenue Growth
13th percentile
Faster revenue growth than 13% of similar nonprofits.
Balance Sheet
Assets
Down$289,774
Down $17,258 (-5.6%) from 2020
Net Assets
Down$289,528
Down $17,073 (-5.6%) from 2020
Liabilities
Down$246
Down $185 (-43%) from 2020
Revenue And Expenses
Revenue
Down$80,414
Down $118,896 (-60%) from 2020
Expenses
Down$119,012
Down $108,013 (-48%) from 2020
Net Income
Down-$38,598
Down $10,883 (-39%) from 2020
Historical Trend
Filing Detail Status
This 2021 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2021 to Dec 31, 2021
Mission and Program Overview
Mission
Mho research is formed to conduct and support research concerning hematologic and oncologic diseases.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2021 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $289,774
- Liabilities
- $246
- Net assets
- $289,528
- Revenue
- $80,414
- Expenses
- $119,012
- Net income
- -$38,598